Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics.
Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeutics. Biochim Biophys Acta Rev Cancer. 2025 Oct; 1880(5):189396.